| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |